To directly examine this, we studied bones from a mouse model of IBD using dextran sodium sulfate (DSS)-induced colitis and investigated the potential of ablating the expression of Socs2 to endogenously elevate GH and IGF-1 function, and correct the bone loss observed in murine colitis. This evidence concerns the gene SOCS2 and inflammatory bowel disease.